Mary Wilson
Well-known member
By Madeline Farber
Published 8 hours ago
Heads up, consumers: A diabetes drug is facing recall because the medication contains excess levels of a cancer-causing agent, the U.S. Food and Drug Administration (FDA) announced this week.
Marksans Pharma Limited, a pharmaceutical company in India, announced an expanded recalled of its Metformin hydrochloride extended-release tablets, a drug used to help those who suffer from type 2 diabetes to lower their blood glucose levels. The recall, which was initially announced in June, was expanded on Monday to include an additional 76 unexpired lots of the medication.
https://www.fox5dc.com/news/diabetes-drug-recalled-over-excess-levels-of-cancer-causing-agent
_______________________________________________________________________________________
FDA link:
Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
https://www.fda.gov/safety/recalls-...l-metformin-hydrochloride#recall-announcement
Published 8 hours ago
Heads up, consumers: A diabetes drug is facing recall because the medication contains excess levels of a cancer-causing agent, the U.S. Food and Drug Administration (FDA) announced this week.
Marksans Pharma Limited, a pharmaceutical company in India, announced an expanded recalled of its Metformin hydrochloride extended-release tablets, a drug used to help those who suffer from type 2 diabetes to lower their blood glucose levels. The recall, which was initially announced in June, was expanded on Monday to include an additional 76 unexpired lots of the medication.
https://www.fox5dc.com/news/diabetes-drug-recalled-over-excess-levels-of-cancer-causing-agent
_______________________________________________________________________________________
FDA link:
Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
https://www.fda.gov/safety/recalls-...l-metformin-hydrochloride#recall-announcement